These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 33268558)

  • 21. Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
    Casadei-Gardini A; Cascinu S; Colombo M
    Gastroenterology; 2021 Mar; 160(4):1423-1424. PubMed ID: 33310087
    [No Abstract]   [Full Text] [Related]  

  • 22. Super refractory status epilepticus secondary to anti-GAD antibody encephalitis successfully treated with aggressive immunotherapy.
    Jaafar F; Haddad L; Koleilat N; Sharara-Chami R; Shbarou R
    Epilepsy Behav Rep; 2020; 14():100396. PubMed ID: 33305253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atezolizumab-induced myositis and myocarditis in a patient with metastatic urothelial carcinoma.
    Sessums M; Yarrarapu S; Guru PK; Sanghavi DK
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33298477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhomboencephalitis.
    Cleaver J; James R; Rice CM
    Pract Neurol; 2020 Dec; ():. PubMed ID: 33293366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma.
    Dang T; Macwan S; Dasanu CA
    J Oncol Pharm Pract; 2021 Sep; 27(6):1534-1538. PubMed ID: 33292071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma.
    Chen HL; Tu YK; Chang HM; Lee TH; Wu KL; Tsai YC; Lee MH; Yang CJ; Hung JY; Chong IW
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches for relapsed CLL after chemotherapy-free frontline regimens.
    Roeker LE; Mato AR
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):10-17. PubMed ID: 33275712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teaching NeuroImages: Hutchinson Sign in Herpes Zoster Ophthalmicus.
    Amano E; Machida A
    Neurology; 2021 Apr; 96(15):e2033-e2034. PubMed ID: 33268563
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of Cerebral Microbleeds With Venous Connection at 7-Tesla MRI.
    Rotta J; Perosa V; Yakupov R; Kuijf HJ; Schreiber F; Dobisch L; Oltmer J; Assmann A; Speck O; Heinze HJ; Acosta-Cabronero J; Duzel E; Schreiber S
    Neurology; 2021 Apr; 96(16):e2048-e2057. PubMed ID: 33653897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurotoxicities associated with immune checkpoint inhibitor therapy.
    Duong SL; Barbiero FJ; Nowak RJ; Baehring JM
    J Neurooncol; 2021 Apr; 152(2):265-277. PubMed ID: 33454891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.
    Abboud H; Probasco JC; Irani S; Ances B; Benavides DR; Bradshaw M; Christo PP; Dale RC; Fernandez-Fournier M; Flanagan EP; Gadoth A; George P; Grebenciucova E; Jammoul A; Lee ST; Li Y; Matiello M; Morse AM; Rae-Grant A; Rojas G; Rossman I; Schmitt S; Venkatesan A; Vernino S; Pittock SJ; Titulaer MJ;
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):757-768. PubMed ID: 33649022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Checkpoint Inhibitor-Associated Striatal Encephalitis Presenting with Subacute Progressive Parkinsonism.
    Prasertpan T; Teeyapun N; Bhidayasiri R; Sringean J
    Mov Disord Clin Pract; 2023 Aug; 10(Suppl 3):S7-S11. PubMed ID: 37636220
    [No Abstract]   [Full Text] [Related]  

  • 33. Hope, Cure, and Adverse Effects in Immunotherapy: Atezolizumab-Associated Encephalitis in Metastatic Small Cell Lung Cancer - A Case Report and Literature Review.
    Ibrahim EY; Zhao WC; Mopuru H; Janowiecki C; Regelmann DJ
    Case Rep Neurol; 2022; 14(3):366-371. PubMed ID: 36824581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature.
    Gao Y; Pan J; Shen D; Peng L; Mao Z; Wang C; Meng H; Zhou Q; Chen S
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case Report: Durvalumab-Associated Encephalitis in Extensive-Stage Small Cell Lung Carcinoma.
    Shionoya Y; Hattori A; Hanada T; Fujino M
    Front Oncol; 2021; 11():693279. PubMed ID: 34249743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Autoimmune Encephalitis.
    Nishijima H; Suzuki C; Kon T; Nakamura T; Tanaka H; Sakamoto Y; Tomiyama M
    Neurology; 2021 Jan; 96(3):126-127. PubMed ID: 33268558
    [No Abstract]   [Full Text] [Related]  

  • 37. Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Encephalitis: A Follow-up Report With Autopsy Findings.
    Nishijima H; Kon T; Seino Y; Yagihashi N; Suzuki C; Nakamura T; Tanaka H; Sakamoto Y; Wakabayashi K; Tomiyama M
    Neurology; 2022 Feb; 98(5):204-205. PubMed ID: 34799464
    [No Abstract]   [Full Text] [Related]  

  • 38. Encephalitis induced by immune checkpoint inhibitors in metastatic melanoma: a monocentric retrospective study.
    Galmiche S; Lheure C; Kramkimel N; Franck N; Boitier F; Dupin N; Turc G; Psimaras D; Aractingi S; Guégan S
    J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):e440-e443. PubMed ID: 31219194
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of subcutaneous immunoglobulin therapy in a patient with autoimmune encephalitis: a case report.
    Lazzaro AT; Romeo L; Gnessi C
    Neurol Sci; 2019 Jan; 40(1):217-220. PubMed ID: 30232671
    [No Abstract]   [Full Text] [Related]  

  • 40. Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review.
    Ogawa K; Kaneda H; Kawamoto T; Tani Y; Izumi M; Matsumoto Y; Sawa K; Suzumura T; Watanabe T; Mitsuoka S; Asai K; Kawaguchi T
    Invest New Drugs; 2020 Dec; 38(6):1901-1905. PubMed ID: 32399862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.